4OSF
4-(2-isothiocyanatoethyl)phenol inhibitor complexed with Macrophage Migration Inhibitory Factor
4OSF の概要
| エントリーDOI | 10.2210/pdb4osf/pdb |
| 関連するPDBエントリー | 3WNR 3WNS 3WNT |
| 分子名称 | Macrophage migration inhibitory factor, N-[2-(4-hydroxyphenyl)ethyl]thioformamide, SULFATE ION, ... (6 entities in total) |
| 機能のキーワード | cytokine, tautomerase, isomerase, benzyl isothiocyante, 4-(2-isothiocyanatoethyl)phenol, isomerase-isomerase inhibitor complex, isomerase/isomerase inhibitor |
| 由来する生物種 | Homo sapiens (human) |
| 細胞内の位置 | Secreted: P14174 |
| タンパク質・核酸の鎖数 | 3 |
| 化学式量合計 | 38892.69 |
| 構造登録者 | Spencer, E.S.,Dale, E.J.,Gommans, A.L.,Vo, C.T.,Rutledge, M.T.,Nakatani, Y.,Gamble, A.B.,Smith, R.A.J.,Wilbanks, S.M.,Hampton, M.B.,Tyndall, J.D.A. (登録日: 2014-02-12, 公開日: 2014-03-12, 最終更新日: 2024-10-30) |
| 主引用文献 | Spencer, E.S.,Dale, E.J.,Gommans, A.L.,Rutledge, M.T.,Vo, C.T.,Nakatani, Y.,Gamble, A.B.,Smith, R.A.,Wilbanks, S.M.,Hampton, M.B.,Tyndall, J.D. Multiple binding modes of isothiocyanates that inhibit macrophage migration inhibitory factor Eur.J.Med.Chem., 93:501-510, 2015 Cited by PubMed Abstract: Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that has roles in the innate immune response, and also contributes to inflammatory disease. While the biological properties of MIF are closely linked to protein-protein interactions, MIF also has tautomerase activity. Inhibition of this activity interferes with the interaction of MIF with protein partners e.g. the CD74 receptor, and tautomerase inhibitors show promise in disease models including multiple sclerosis and colitis. Isothiocyanates inhibit MIF tautomerase activity via covalent modification of the N-terminal proline. We systematically explored variants of benzyl and phenethyl isothiocyanates, to define determinants of inhibition. In particular, substitution with hydroxyl, chloro, fluoro and trifluoro moieties at the para and meta positions were evaluated. In assays on treated cells and recombinant protein, the IC50 varied from 250 nM to >100 μM. X-ray crystal structures of selected complexes revealed that two binding modes are accessed by some compounds, perhaps owing to strain in short linkers between the isothiocyanate and aromatic ring. The variety of binding modes confirms the existence of two subsites for inhibitors and establishes a platform for the development of potent inhibitors of MIF that only need to target one of these subsites. PubMed: 25743213DOI: 10.1016/j.ejmech.2015.02.012 主引用文献が同じPDBエントリー |
| 実験手法 | X-RAY DIFFRACTION (1.62 Å) |
構造検証レポート
検証レポート(詳細版)
をダウンロード






